Pamela Fradkin
Overview
Explore the profile of Pamela Fradkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davis S, Panjari M, Robinson P, Fradkin P, Bell R
Menopause
. 2014 Mar;
21(10):1075-81.
PMID: 24618765
Objective: We investigated the prevalence and severity of menopausal symptoms, nearly 6 years from diagnosis, in women who had not experienced recurrent breast cancer or a new primary breast cancer...
2.
Bell R, Robinson P, Nazeem F, Panjari M, Fradkin P, Schwarz M, et al.
J Cancer Surviv
. 2013 Aug;
8(1):1-8.
PMID: 23975613
Purpose: The aim of our study was to establish the prevalence of breast pain persisting 5 years after the initial treatment of breast cancer (BC) and the relationship between those...
3.
Bell R, Schwarz M, Fradkin P, Robinson P, Davis S
Menopause
. 2013 Jun;
20(7):721-6.
PMID: 23793165
Objective: Oral adjuvant endocrine therapy (OAET) substantially improves the survival of women with hormone receptor-positive (HR) breast cancer. However, we reported previously that at 3 to 4 years after diagnosis,...
4.
Bell R, Fradkin P, Parathithasan N, Robinson P, Schwarz M, Davis S
Breast
. 2013 Jun;
22(5):980-5.
PMID: 23791664
Background: This study examined pregnancy-associated breast cancer (PABC) and pregnancy following treatment for breast cancer. Methods: We analysed data from a questionnaire-based, prospective study of women diagnosed with breast cancer....
5.
Bell R, Robinson P, Barallon R, Fradkin P, Schwarz M, Davis S
Support Care Cancer
. 2013 Feb;
21(7):2017-24.
PMID: 23435596
Purpose: The aim of this work was to study the incidence and prevalence of self-reported lymphedema in breast cancer survivors between 2 and 4 years following diagnosis, the factors associated...
6.
Bell R, Schwarz M, Fradkin P, Davis S
ANZ J Surg
. 2012 Sep;
83(3):129-34.
PMID: 22985255
Background: There is no evidence of benefit in terms of survival or quality of life for intensive surveillance of women with early breast cancer (BC) and current guidelines reflect this....
7.
Bell R, Fradkin P, Schwarz M, Davis S
Menopause
. 2012 Sep;
20(1):15-21.
PMID: 22948136
Objective: The aim of this study was to investigate the extent of discontinuation of oral adjuvant endocrine therapy (OAET) in women nearly 4 years from the diagnosis of their first...
8.
Panjari M, Bell R, Lijovic M, La China M, Schwarz M, Fradkin P, et al.
Horm Cancer
. 2011 Jul;
1(2):93-9.
PMID: 21761352
Exposure to postmenopausal hormone therapy (HT) may affect the stage, histological type, and hormone receptor (HR) status of invasive breast cancer at the time of diagnosis. One thousand six hundred...
9.
Bell R, Lijovic M, Fradkin P, Schwarz M, Davis S
Support Care Cancer
. 2011 Apr;
20(4):783-9.
PMID: 21479524
Purpose: Smoking and alcohol consumption after breast cancer diagnosis have received little attention. The aim of this study was to describe the change in smoking and alcohol consumption of women...
10.
Panjari M, Davis S, Fradkin P, Bell R
Psychooncology
. 2011 Mar;
21(7):724-9.
PMID: 21384468
Objective: To explore the beliefs held by breast cancer (BC) survivors about the factors that contribute to the development of their BC. Methods: The BUPA Health Foundation Health and Well-being...